|1.||Johnson, Peter F: 7 articles (05/2009 - 01/2002)|
|2.||Kim, Sang Geon: 5 articles (04/2009 - 02/2005)|
|3.||Leutz, Achim: 4 articles (03/2010 - 09/2005)|
|4.||Akira, Shizuo: 4 articles (01/2010 - 10/2007)|
|5.||Timchenko, Nikolai A: 3 articles (07/2010 - 05/2005)|
|6.||Smink, Jeske J: 3 articles (03/2010 - 06/2009)|
|7.||Dörken, Bernd: 3 articles (01/2010 - 09/2005)|
|8.||Kang, Keon Wook: 3 articles (01/2010 - 06/2007)|
|9.||Sun, Li: 3 articles (06/2009 - 12/2003)|
|10.||Sebastian, Thomas: 3 articles (03/2009 - 09/2004)|
11/01/2008 - "These results indicate that C/EBPbeta represses p53 to promote cell survival downstream of DNA damage and suggest that inhibition of C/EBPbeta may be a target for cancer cotherapy to increase the efficacy of alkylating chemotherapeutic agents."
08/01/2015 - "Recently, CCAAT/enhancer binding protein beta (C/EBPβ) has been investigated as a tumor suppressor that participates in tumor invasion. "
08/01/2010 - "Furthermore, the expression of the tumor suppressor p53 and the cell cycle inhibitors p21 and p27 was markedly elevated in C/EBPbeta-null stromal cells before the mitotic phase, uncovering additional mechanisms by which C/EBPbeta controls G2 to M transition. "
10/01/2009 - "Further analysis showed that induction of miR-155 suppressed C/EBPbeta protein expression as well as cytokine production in tumor-activated monocytes, an effect which could be mimicked by silencing of C/EBPbeta. "
10/01/2009 - "Moreover, we found that C/EBPbeta expression was regulated at the post-transcriptional level and correlated with sustained reduction of microRNA-155 (miR-155) in tumor-activated monocytes. "
03/16/2007 - "Our work uncovers a novel role for C/EBPbeta as a mediator of PPARdelta-dependent 14-3-3epsilon gene regulation in human endothelial cells and provides insight into the mechanism by which PPARdelta agonists may be beneficial in atherosclerosis."
09/01/2010 - "Changes in atherosclerosis were paralleled by changes in the expression of the inflammation markers (C-reactive protein, monocyte chemotactic protein-1, interleukin-6, nuclear factor kappa B and intercellular adhesion molecule-1) in peritoneal macrophages obtained from these mice. "
09/14/2007 - "These results, confirmed in primary human hepatocytes and CASMC, demonstrate for the first time that IL-17 is a potent inducer of CRP expression via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation and suggest that IL-17 may mediate chronic inflammation, atherosclerosis, and thrombosis."
|3.||Acute Promyelocytic Leukemia
12/01/1998 - "In order to identify the downstream genes of NF-IL6 in a monocytic lineage, we combined an inducible expression system with subtraction cloning in a study of murine M1 monocytic leukemia cells. "
02/01/1997 - "This is significantly different from the apparent effects of NF-IL6 in leukemia cells and in fibroblasts. "
08/28/2009 - "In this study, interactions between C/EBPbeta and either the Abelson murine leukemia viral oncogene homolog 1 (c-Abl) or the Abl-related gene (Arg) were demonstrated in vitro and in vivo with a direct binding assay and by co-immunoprecipitation, respectively. "
10/16/2009 - "Co-expression of promyelocytic leukemia protein abrogated the repressive effect of Daxx on C/EBPbeta as well as the direct interaction of Daxx and C/EBPbeta, presumably by re-recruiting Daxx to PML-oncogenic domains. "
11/03/2003 - "We further provide evidence that ATRA mediates a direct increase of C/EBPbeta, only in PML-RARA (promyelocytic leukemia-retinoic acid receptor alpha)-expressing cells. "
|5.||Hepatocellular Carcinoma (Hepatoma)
01/01/2013 - "In the present study we used the rainbow trout hepatoma (RTH-149) cell line to further examine the involvement of NF-IL6 and AP1 in rtMT-A gene expression following exposure to oxidative stress and tumour promotion. "
06/01/2011 - "In this study, we used the opposing transcriptional effects driven by LAP and LIP to determine the genuine C/EBPbeta molecular signature in the Hep3B human hepatoma cell line. "
09/27/1996 - "Previous studies have shown that in human T-cells (Jurkat) and hepatoma cells (HepG2), exogenous NF-IL6 can activate HIV-1 gene expression even in the absence of its consensus binding elements in the viral long terminal repeat (LTR). "
10/01/1996 - "In contrast, overexpression of C/EBP beta or C/EBP delta had no effect on hepatoma cell growth. "
09/06/1996 - "Additionally the inhibitory role of C/EBP-beta/LAP on the albumin minimal promoter could be confirmed by transfection experiments in hepatoma cells. "
|2.||Tretinoin (Retinoic Acid)
|3.||Transcription Factors (Transcription Factor)
|4.||NF-kappa B (NF-kB)
|7.||Interleukin-6 (Interleukin 6)
|9.||Protein Isoforms (Isoforms)
|5.||Induced Hyperthermia (Thermotherapy)